208
Participants
Start Date
August 17, 2016
Primary Completion Date
August 23, 2017
Study Completion Date
August 23, 2017
RBP-6000
Monthly injections subcutaneously on alternate sides of participant's abdomen. Dose could be adjusted from 100 mg to 300 mg (or the reverse) based on the medical judgment of the investigator.
Keystone Clinical Solutions, Altoona
Carolina Clinical Trials, Charleston
Amit Vijapura, Jacksonville
Sarkis Clinical Trials, Gainesville
Scientific Clinical Research, North Miami
Innovative Clinical Research, Lauderhill
Meridien Research, Lakeland
Boyett Health Services, Hamilton
Precise Research Centers, Inc., Flowood
Rakesh Ranjan MD & Associates, Inc., Garfield Heights
Neuro-behavioral Clinical Research, Canton
Midwest Clinical Research Center, Dayton
St Louis Clinical Trials, St Louis
Phoenix Medical Research, Prairie Village
Louisiana Research Associates, New Orleans
Louisiana Clinical Research, Shreveport
Woodland International Research Group, Little Rock
Pahl Pharmaceutical Professionals, Oklahoma City
SP Research, PLLC, Oklahoma City
InSite Clinical Research, DeSoto
Pillar Clinical Research, Dallas
Altea Research, Las Vegas
Collaborative Neuroscience Network, Long Beach
Pacific Research Partners, Oakland
CODA, Portland
Stanley Street Treatment and Resources, Fall River
Adams Clinical Trials, Watertown
Hassman Research Institute, Berlin
Center for Emotional Fitness, Cherry Hill
Lead Sponsor
Indivior Inc.
INDUSTRY